Targeting EGFR-PI3K-AKT-mTOR signaling enhances radiosensitivity in head and neck squamous cell carcinoma

Dominik HornUniversity Hospital Heidelberg, Department of Oral and Maxillofacial Surgery, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany+49 0 6221 56 38462; +49 0 6221 56 4222; [email protected]

Jochen HessUniversity Hospital Heidelberg, Section Experimental and Translational Head and Neck Oncology, Department of Otolaryngology, Heidelberg, Germany;German Cancer Research Center (DKFZ), Research Group Molecular Mechanisms of Head and Neck Tumors, Heidelberg, Germany

Kolja FreierUniversity Hospital Heidelberg, Department of Oral and Maxillofacial Surgery, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany+49 0 6221 56 38462; +49 0 6221 56 4222; [email protected]

Jürgen HoffmannUniversity Hospital Heidelberg, Department of Oral and Maxillofacial Surgery, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany+49 0 6221 56 38462; +49 0 6221 56 4222; [email protected]

Christian FreudlspergerUniversity Hospital Heidelberg, Department of Oral and Maxillofacial Surgery, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany+49 0 6221 56 38462; +49 0 6221 56 4222; [email protected]

Targeting EGFR-PI3K-AKT-mTOR signaling enhances radiosensitivity in head and neck squamous cell carcinoma

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Targeting EGFR-PI3K-AKT-mTOR signaling enhances radiosensitivity in head and neck squamous cell carcinoma

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date